Universal-Beteiligungs- und Servicegesellschaft’s Denali Therapeutics DNLI Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.61M	Buy	179,195 +79,692	+80%	+$1.64M	0.01%	968
2026 Q1	$1.91M	Buy	99,503 +28,673	+40%	+$571K	﹤0.01%	1264
2025 Q4	$1.17M	Buy	70,830 +44,607	+170%	+$753K	﹤0.01%	1444
2025 Q3	$381K	Buy	26,223 +4,739	+22%	+$68.1K	﹤0.01%	1828
2025 Q2	$301K	Buy	21,484 +2,785	+15%	+$39.2K	﹤0.01%	1830
2025 Q1	$254K	Buy	+18,699	New	+$358K	﹤0.01%	1831

Other funds holding DNLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's DNLI Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Denali Therapeutics (DNLI) stake by 80% in Q2 2026, buying an estimated $1.64M and bringing the position to 179,195 shares worth $4.61M. The position accounts for 0.01% of the portfolio, ranked #968.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DNLI in Q1 2025 and has held it in 6 quarters since. 167 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 179,195 shares of Denali Therapeutics worth $4.61M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft bought 79,692 Denali Therapeutics shares in Q2 2026, an estimated $1.64M.
Denali Therapeutics made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #968 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Denali Therapeutics in Q1 2025 and has held it in 6 quarters since.
167 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.